tiprankstipranks
Evommune, Inc. (EVMN)
NYSE:EVMN
US Market
EVMN
Evommune, Inc.
RESEARCH TOOLSreports
Want to see EVMN full AI Analyst Report?

Evommune, Inc. (EVMN) Stock Forecast & Price Target

136 Followers
See the Price Targets and Ratings of:

EVMN Analyst Ratings

Moderate Buy
7Ratings
Moderate Buy
5 Buy
2 Hold
0 Sell
Based on 7 analysts giving stock ratings to
Evommune,
Inc.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

EVMN Stock 12 Month Forecast

Average Price Target

$27.00
▲(84.30% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Evommune, Inc. in the last 3 months. The average price target is $27.00 with a high forecast of $30.00 and a low forecast of $22.00. The average price target represents a 84.30% change from the last price of $14.65.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"10":"$10","31":"$31","15.25":"$15.25","20.5":"$20.5","25.75":"$25.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":30,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$30.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":27,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$27.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":22,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$22.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[10,15.25,20.5,25.75,31],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.25,12.692307692307692,14.134615384615385,15.576923076923077,17.01923076923077,18.46153846153846,19.903846153846153,21.346153846153847,22.78846153846154,24.23076923076923,25.673076923076923,27.115384615384613,28.557692307692307,{"y":30,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.25,12.461538461538462,13.673076923076923,14.884615384615383,16.096153846153847,17.307692307692307,18.519230769230766,19.73076923076923,20.942307692307693,22.153846153846153,23.365384615384613,24.576923076923077,25.788461538461537,{"y":27,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.25,12.076923076923077,12.903846153846153,13.73076923076923,14.557692307692307,15.384615384615383,16.21153846153846,17.03846153846154,17.865384615384613,18.692307692307693,19.519230769230766,20.346153846153847,21.173076923076923,{"y":22,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":20.23,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":20.23,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":20.23,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":20.23,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":20.91,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.12,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.23,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.61,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.42,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.5,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.17,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.82,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.25,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$30.00Average Price Target$27.00Lowest Price Target$22.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus Analyst forecast on EVMN
Alex Thompson CFA
Stifel Nicolaus
Stifel Nicolaus
$30
Buy
104.78%
Upside
Reiterated
08/11/26
Analysts Are Bullish on Top NA Stocks: BitGo Holdings, Inc. Class A (BTGO), Evommune, Inc. (EVMN)
Evercore ISI Analyst forecast on EVMN
Gavin Clark-Gartner
Evercore ISI
Evercore ISI
$22
Buy
50.17%
Upside
Reiterated
08/10/26
Evercore ISI Keeps Their Buy Rating on Evommune, Inc. (EVMN)
Morgan Stanley Analyst forecast on EVMN
Judah Frommer
Morgan Stanley
Morgan Stanley
$26
Buy
77.47%
Upside
Assigned
08/10/26
Analysts Conflicted on These NA Names: TripAdvisor (NASDAQ: TRIP), Evommune, Inc. (NYSE: EVMN) and StandardAero, Inc. (NYSE: SARO)
H.C. Wainwright Analyst forecast on EVMN
Mitchell Kapoor
H.C. Wainwright
H.C. Wainwright
―
Hold
―
Reiterated
08/07/26
Analysts Conflicted on These NA Names: Bob's Discount Furniture, Inc. (NYSE: BOBS), Evommune, Inc. (NYSE: EVMN) and Once Upon a Farm, PBC (NYSE: OFRM)
William Blair Analyst forecast on EVMN
Matt Phipps
William Blair
William Blair
―
Hold
―
Reiterated
08/07/26
Analysts Conflicted on These NA Names: Fiserv (NASDAQ: FISV), Evommune, Inc. (NYSE: EVMN) and Waystar Holding Corp. (NASDAQ: WAY)
RBC Capital Analyst forecast on EVMN
Brian Abrahams
RBC Capital
RBC Capital
$30→$29
Buy
97.95%
Upside
Reiterated
08/06/26
RBC Capital Reaffirms Their Buy Rating on Evommune, Inc. (EVMN)
Clear Street Analyst forecast on EVMN
Kaveri Pohlman
Clear Street
Clear Street
$28
Buy
91.13%
Upside
Reiterated
07/16/26
Clear Street sees attractive point into Evommune after selloffClear Street sees attractive point into Evommune after selloff
Oppenheimer Analyst forecast on EVMN
Kostas Biliouris
Oppenheimer
Oppenheimer
$50
Buy
241.30%
Upside
Reiterated
05/15/26
Oppenheimer Sticks to Its Buy Rating for Evommune, Inc. (EVMN)
Leerink Partners Analyst forecast on EVMN
Thomas Smith
Leerink Partners
Leerink Partners
$52
Buy
254.95%
Upside
Reiterated
03/06/26
Evommune, Inc. (EVMN) Receives a Rating Update from a Top Analyst
Raymond James Analyst forecast on EVMN
Martin Auster
Raymond James
Raymond James
$40
Buy
173.04%
Upside
Reiterated
01/26/26
Evommune, Inc. (EVMN) Receives a Buy from Raymond James
Chardan Capital Analyst forecast on EVMN
Andreas Argyrides
Chardan Capital
Chardan Capital
$42
Buy
186.69%
Upside
Initiated
01/23/26
Evommune initiated with an Outperform at OppenheimerEvommune initiated with an Outperform at Oppenheimer
Cantor Fitzgerald Analyst forecast on EVMN
Prakhar Agrawal
Cantor Fitzgerald
Cantor Fitzgerald
―
Buy
―
Initiated
12/01/25
Evommune initiated with an Overweight at Cantor FitzgeraldEvommune initiated with an Overweight at Cantor Fitzgerald
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus Analyst forecast on EVMN
Alex Thompson CFA
Stifel Nicolaus
Stifel Nicolaus
$30
Buy
104.78%
Upside
Reiterated
08/11/26
Analysts Are Bullish on Top NA Stocks: BitGo Holdings, Inc. Class A (BTGO), Evommune, Inc. (EVMN)
Evercore ISI Analyst forecast on EVMN
Gavin Clark-Gartner
Evercore ISI
Evercore ISI
$22
Buy
50.17%
Upside
Reiterated
08/10/26
Evercore ISI Keeps Their Buy Rating on Evommune, Inc. (EVMN)
Morgan Stanley Analyst forecast on EVMN
Judah Frommer
Morgan Stanley
Morgan Stanley
$26
Buy
77.47%
Upside
Assigned
08/10/26
Analysts Conflicted on These NA Names: TripAdvisor (NASDAQ: TRIP), Evommune, Inc. (NYSE: EVMN) and StandardAero, Inc. (NYSE: SARO)
H.C. Wainwright Analyst forecast on EVMN
Mitchell Kapoor
H.C. Wainwright
H.C. Wainwright
―
Hold
―
Reiterated
08/07/26
Analysts Conflicted on These NA Names: Bob's Discount Furniture, Inc. (NYSE: BOBS), Evommune, Inc. (NYSE: EVMN) and Once Upon a Farm, PBC (NYSE: OFRM)
William Blair Analyst forecast on EVMN
Matt Phipps
William Blair
William Blair
―
Hold
―
Reiterated
08/07/26
Analysts Conflicted on These NA Names: Fiserv (NASDAQ: FISV), Evommune, Inc. (NYSE: EVMN) and Waystar Holding Corp. (NASDAQ: WAY)
RBC Capital Analyst forecast on EVMN
Brian Abrahams
RBC Capital
RBC Capital
$30→$29
Buy
97.95%
Upside
Reiterated
08/06/26
RBC Capital Reaffirms Their Buy Rating on Evommune, Inc. (EVMN)
Clear Street Analyst forecast on EVMN
Kaveri Pohlman
Clear Street
Clear Street
$28
Buy
91.13%
Upside
Reiterated
07/16/26
Clear Street sees attractive point into Evommune after selloffClear Street sees attractive point into Evommune after selloff
Oppenheimer Analyst forecast on EVMN
Kostas Biliouris
Oppenheimer
Oppenheimer
$50
Buy
241.30%
Upside
Reiterated
05/15/26
Oppenheimer Sticks to Its Buy Rating for Evommune, Inc. (EVMN)
Leerink Partners Analyst forecast on EVMN
Thomas Smith
Leerink Partners
Leerink Partners
$52
Buy
254.95%
Upside
Reiterated
03/06/26
Evommune, Inc. (EVMN) Receives a Rating Update from a Top Analyst
Raymond James Analyst forecast on EVMN
Martin Auster
Raymond James
Raymond James
$40
Buy
173.04%
Upside
Reiterated
01/26/26
Evommune, Inc. (EVMN) Receives a Buy from Raymond James
Chardan Capital Analyst forecast on EVMN
Andreas Argyrides
Chardan Capital
Chardan Capital
$42
Buy
186.69%
Upside
Initiated
01/23/26
Evommune initiated with an Outperform at OppenheimerEvommune initiated with an Outperform at Oppenheimer
Cantor Fitzgerald Analyst forecast on EVMN
Prakhar Agrawal
Cantor Fitzgerald
Cantor Fitzgerald
―
Buy
―
Initiated
12/01/25
Evommune initiated with an Overweight at Cantor FitzgeraldEvommune initiated with an Overweight at Cantor Fitzgerald
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Evommune, Inc.

3 Months
Gavin Clark-GartnerEvercore ISI
Success Rate
2/3 ratings generated profit
67%
Average Return
+1.20%
Copying Gavin Clark-Gartner's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +1.20% per trade.
1 Year
Kaveri PohlmanClear Street
Success Rate
1/3 ratings generated profit
33%
Average Return
-9.70%
Copying Kaveri Pohlman's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -9.70% per trade.
2 Years
Kaveri PohlmanClear Street
Success Rate
1/3 ratings generated profit
33%
Average Return
-9.70%
Copying Kaveri Pohlman's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -9.70% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

EVMN Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
13
16
14
12
10
Buy
5
6
5
3
1
Hold
0
0
2
2
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
18
22
21
17
16
In the current month, EVMN has received 11 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. EVMN average Analyst price target in the past 3 months is 27.00.
Each month's total comprises the sum of three months' worth of ratings.

EVMN Financial Forecast

EVMN Earnings Forecast

Next quarter’s earnings estimate for EVMN is -$0.83 with a range of -$1.01 to -$0.64. The previous quarter’s EPS was -$0.89. EVMN beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year EVMN has Outperformed its overall industry.
Next quarter’s earnings estimate for EVMN is -$0.83 with a range of -$1.01 to -$0.64. The previous quarter’s EPS was -$0.89. EVMN beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year EVMN has Outperformed its overall industry.

EVMN Sales Forecast

Next quarter’s sales forecast for EVMN is $500.00K with a range of $0.00 to $3.00M. The previous quarter’s sales results were $0.00. EVMN beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year EVMN has Outperformed its overall industry.
Next quarter’s sales forecast for EVMN is $500.00K with a range of $0.00 to $3.00M. The previous quarter’s sales results were $0.00. EVMN beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year EVMN has Outperformed its overall industry.

EVMN Stock Forecast FAQ

What is EVMN’s average 12-month price target, according to analysts?
Based on analyst ratings, Evommune, Inc.’s 12-month average price target is 27.00.
    What is EVMN’s upside potential, based on the analysts’ average price target?
    Evommune, Inc. has 84.30% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is EVMN a Buy, Sell or Hold?
          Evommune, Inc. has a consensus rating of Moderate Buy which is based on 5 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Evommune, Inc.’s price target?
            The average price target for Evommune, Inc. is 27.00. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $30.00 ,the lowest forecast is $22.00. The average price target represents 84.30% Increase from the current price of $14.65.
              What do analysts say about Evommune, Inc.?
              Evommune, Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of EVMN?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.